Evidence map›Paper›PMID 37959741›Full record

ArticleMolecules (Basel, Switzerland)2023

How to More Effectively Obtain Ginsenoside Rg5: Understanding Pathways of Conversion.

Leqin Cheng, Wei Luo, Anqi Ye, Yuewei Zhang, Ling Li, Haijiao Xie

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Leqin ChengJilin Institute of Chemical Technology, School of Chemistry and Pharmaceutical Engineering, Jilin 132022, China.
Wei LuoJilin Institute of Chemical Technology, School of Chemistry and Pharmaceutical Engineering, Jilin 132022, China.
Anqi YeJilin Institute of Chemical Technology, School of Chemistry and Pharmaceutical Engineering, Jilin 132022, China.
Yuewei ZhangJilin Institute of Chemical Technology, School of Chemistry and Pharmaceutical Engineering, Jilin 132022, China.ORCID 0000-0001-6696-0336
Ling LiTonghua Bai'aojinsen Biotechnology Co., Ltd., Tonghua 134000, China.
Haijiao XieHangzhou Yanqu Information Technology Co., Ltd., Hangzhou 310003, China.

Funding

Jilin Provincial Science and Technology Development Program YYZX202009
6 · The paper itself

Abstract

Ginsenoside Rg5, a relatively uncommon secondary ginsenoside, exhibits notable pharmacological activity and is commonly hypothesized to originate from the dehydration of Rg3. In this work, we compared different conversion pathways using Rb1,

Indexed as

GinsenosidesPanaxDehydrationMagnetic Resonance SpectroscopyMolecular Conformationginsenoside Rg5Ginsenosidesconversion pathwayDFT calculationsNOESY analysisrare ginsenoside Rg5

Identifiers

PMID37959741
PMCPMC10650205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.